Neuren Pharmaceuticals reported AUD2.33M in Selling and Administration Expenses for its fiscal semester ending in December of 2024.


Selling And Administration Expenses Change Date
Alaunos Therapeutics USD 845K 162K Dec/2024
Avita Medical AUD 21.23M 2.57M Dec/2024
Clinuvel Pharmaceuticals AUD 16.21M 3.62M Jun/2024
Dianthus Therapeutics USD 8.87M 2.04M Jun/2025
Genetic Signatures AUD 10.52M 1.03M Dec/2024
Ionis Pharmaceuticals USD 90.6M 14.6M Jun/2025
Medical Developments International AUD 12.94M 5.87M Dec/2024
Neuren Pharmaceuticals AUD 2.33M 47K Dec/2024
Organon & Co USD 453M 33M Jun/2025
Paradigm Biopharmaceuticals AUD 2.36M 639.57K Dec/2024
PYC Therapeutics AUD 2.58M 1.57M Dec/2024
Starpharma Holdings AUD 3.13M 1.31M Dec/2024
Tectonic Therapeutic USD 5.15M 315K Jun/2025
Telix Pharmaceuticals AUD 55.91M 31.78M Dec/2024
Viatris USD 928.7M 111.2M Jun/2025
Xeris Pharmaceuticals USD 44.39M 35.89M Jun/2025